Herriot Tabuteau, CEO: Axsome Therapeutics AXSM Planned sale · Filed 01/06

Trade details

Type: Planned sale notice
Stock: Axsome Therapeutics AXSM
Person: Herriot TabuteauCEO
Planned sale date: 26/01/06
Filed: 26/01/06

More to sell after $52.4M in 3 months

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/07~02/05

Herriot Tabuteau's recent trades

Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$979.2K
4,660 sh
$979.2K
Filed 08/06
Traded 08/06
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$9.6M
45,004 sh
$9.6M
Filed 08/05
Traded 08/05
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$12M
49,666 sh
$12M
Filed 07/01
Traded 07/01
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$12.2M
49,670 sh
$12.2M
Filed 06/09
Traded 06/09
Herriot TabuteauCEO
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$12M
49,670 sh
$12M
Filed 06/09
Traded 06/09

Herriot Tabuteau, CEO — plans to sell 29,450 sh of Axsome Therapeutics AXSM · $5.1M · around 01/06 · 10b5-1 plan | Whalegun